We previously showed that targeted deubiquitination with enDUB-O1 could rescue trafficking deficient mutations in KCNQ1 and cystic fibrosis transmembrane regulator (CFTR) that cause LQT1 and CF, respectively29. This evidence concerns the gene KCNQ1 and long QT syndrome 1.